FOLH1 and neoplasm: Following a series of validations, the researchers discovered that the performance of ultrasonography and PAI using PSMAP/ICG NB in PSMA+ tumor xenografts was drastically elevated compared to the PSMA- tumors, resulting in a noticeable prolongation of both ultrasound and photoacoustic signal intensity enhancements.